Related references
Note: Only part of the references are listed.Molecular Mechanisms of DUBs Regulation in Signaling and Disease
Ying Li et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Advances in the Development Ubiquitin-Specific Peptidase (USP) Inhibitors
Shiyao Chen et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
USP22 promotes melanoma and BRAF inhibitor resistance via YAP stabilization
Ying Wei et al.
ONCOLOGY LETTERS (2021)
Pharmacological inhibition of USP7 suppresses growth and metastasis of melanoma cells in vitro and in vivo
Minmin Xiang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2021)
Time-resolved in vivo ubiquitinome profiling by DIA-MS reveals USP7 targets on a proteome-wide scale
Martin Steger et al.
NATURE COMMUNICATIONS (2021)
Proteome Analysis of USP7 Substrates Revealed Its Role in Melanoma Through PI3K/Akt/FOXO and AMPK Pathways (vol 11, 650165, 2021)
Lanyang Gao et al.
FRONTIERS IN ONCOLOGY (2021)
Inhibition of USP7 activity selectively eliminates senescent cells in part via restoration of p53 activity
Yonghan He et al.
AGING CELL (2020)
Potent USP10/13 antagonist spautin-1 suppresses melanoma growth via ROS-mediated DNA damage and exhibits synergy with cisplatin
Jia Guo et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
Therapy-Induced Senescence: An Old Friend Becomes the Enemy
Tareq Saleh et al.
CANCERS (2020)
Histone Deacetylase Inhibitors to Overcome Resistance to Targeted and Immuno Therapy in Metastatic Melanoma
Minjeong Yeon et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
ShcD Binds DOCK4, Promotes Ameboid Motility and Metastasis Dissemination, Predicting Poor Prognosis in Melanoma
Ewa Aladowicz et al.
CANCERS (2020)
A Novel Mechanism Driving Poor-Prognosis Prostate Cancer: Overexpression of the DNA Repair Gene, Ribonucleotide Reductase Small Subunit M2 (RRM2)
Ying Z. Mazzu et al.
CLINICAL CANCER RESEARCH (2019)
Ribonucleotide reductase subunit M2 as a novel target for clear-cell renal cell carcinoma
Yun Zou et al.
ONCOTARGETS AND THERAPY (2019)
Targeting senescent cells: approaches, opportunities, challenges
Cayetano von Kobbe
AGING-US (2019)
Deubiquitinating Enzymes: A Critical Regulator of Mitosis
Jinyoung Park et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
USP7 is a novel Deubiquitinase sustaining PLK1 protein stability and regulating chromosome alignment in mitosis
Yuchong Peng et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Targeting USP7 Identifies a Metastasis-Competent State within Bone Marrow-Resident Melanoma CTCs
Monika Vishnoi et al.
CANCER RESEARCH (2018)
Is DNA damage indispensable for stress-induced senescence?
Anna Bielak-Zmijewska et al.
MECHANISMS OF AGEING AND DEVELOPMENT (2018)
USP7: Target Validation and Drug Discovery for Cancer Therapy
Jin Zhou et al.
MEDICINAL CHEMISTRY (2018)
Emerging insights into HAUSP (USP7) in physiology, cancer and other diseases
Seemana Bhattacharya et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2018)
The STRING database in 2017: quality-controlled protein-protein association networks, made broadly accessible
Damian Szklarczyk et al.
NUCLEIC ACIDS RESEARCH (2017)
Cellular Senescence Promotes Adverse Effects of Chemotherapy and Cancer Relapse
Marco Demaria et al.
CANCER DISCOVERY (2017)
USP7 small-molecule inhibitors interfere with ubiquitin binding
Lorna Kategaya et al.
NATURE (2017)
Molecular basis of USP7 inhibition by selective small-molecule inhibitors
Andrew P. Turnbull et al.
NATURE (2017)
Shortage of dNTPs underlies altered replication dynamics and DNA breakage in the absence of the APC/C cofactor Cdh1
J. Garzon et al.
ONCOGENE (2017)
Stepwise assembly of functional C-terminal REST/NRSF transcriptional repressor complexes as a drug target
Ken Inui et al.
PROTEIN SCIENCE (2017)
The Dual Role of Cellular Senescence in Developing Tumors and Their Response to Cancer Therapy
Markus Schosserer et al.
FRONTIERS IN ONCOLOGY (2017)
Induction of Therapeutic Senescence in Vemurafenib-Resistant Melanoma by Extended Inhibition of CDK4/6
Akihiro Yoshida et al.
CANCER RESEARCH (2016)
Drugging the undruggables: exploring the ubiquitin system for drug development
Xiaodong Huang et al.
CELL RESEARCH (2016)
Targeting RRM2 and Mutant BRAF Is a Novel Combinatorial Strategy for Melanoma
Nail Fatkhutdinov et al.
MOLECULAR CANCER RESEARCH (2016)
The MaxQuant computational platform for mass spectrometry-based shotgun proteomics
Stefka Tyanova et al.
NATURE PROTOCOLS (2016)
USP7 is a SUMO deubiquitinase essential for DNA replication
Emilio Lecona et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2016)
Stabilization of LSD1 by deubiquitinating enzyme USP7 promotes glioblastoma cell tumorigenesis and metastasis through suppression of the p53 signaling pathway
Lei Yi et al.
ONCOLOGY REPORTS (2016)
In Vivo Genetic Screens of Patient-Derived Tumors Revealed Unexpected Frailty of the Transformed Phenotype
Daniela Bossi et al.
CANCER DISCOVERY (2016)
USP7 is a SUMO deubiquitinase essential for DNA replication
Emilio Lecona et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2016)
USP7 Enforces Heterochromatinization of p53 Target Promoters by Protecting SUV39H1 from MDM2-Mediated Degradation
Sathish Kumar Mungamuri et al.
CELL REPORTS (2016)
mTORC1 Activation Blocks BrafV600E-Induced Growth Arrest but Is Insufficient for Melanoma Formation
William Damsky et al.
CANCER CELL (2015)
USP7 deubiquitinase promotes ubiquitin-dependent DNA damage signaling by stabilizing RNF168*
Qianzheng Zhu et al.
CELL CYCLE (2015)
Persistent γH2AX: A promising molecular marker of DNA damage and aging
Mohammad Sabbir Siddiqui et al.
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH (2015)
Deubiquitinase inhibition as a cancer therapeutic strategy
Padraig D'Arcy et al.
PHARMACOLOGY & THERAPEUTICS (2015)
HTSeq-a Python framework to work with high-throughput sequencing data
Simon Anders et al.
BIOINFORMATICS (2015)
Accurate Proteome-wide Label-free Quantification by Delayed Normalization and Maximal Peptide Ratio Extraction, Termed MaxLFQ
Juergen Cox et al.
MOLECULAR & CELLULAR PROTEOMICS (2014)
Expression of RRM1 and RRM2 as a novel prognostic marker in advanced non-small cell lung cancer receiving chemotherapy
Lei Wang et al.
TUMOR BIOLOGY (2014)
Characteristics and Associations of High-Mitotic-Rate Melanoma
Sarah Shen et al.
JAMA DERMATOLOGY (2014)
Depletion of Deoxyribonucleotide Pools Is an Endogenous Source of DNA Damage in Cells Undergoing Oncogene-Induced Senescence
Sudha Mannava et al.
AMERICAN JOURNAL OF PATHOLOGY (2013)
USP7 and Daxx regulate mitosis progression and taxane sensitivity by affecting stability of Aurora-A kinase
S. Giovinazzi et al.
CELL DEATH AND DIFFERENTIATION (2013)
RRM2 Regulates Bcl-2 in Head and Neck and Lung Cancers: A Potential Target for Cancer Therapy
Mohammad Aminur Rahman et al.
CLINICAL CANCER RESEARCH (2013)
Suppression of Nucleotide Metabolism Underlies the Establishment and Maintenance of Oncogene-Induced Senescence
Katherine M. Aird et al.
CELL REPORTS (2013)
TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions
Daehwan Kim et al.
GENOME BIOLOGY (2013)
Cyclin F-Mediated Degradation of Ribonucleotide Reductase M2 Controls Genome Integrity and DNA Repair
Vincenzo D'Angiolella et al.
CELL (2012)
NIH Image to ImageJ: 25 years of image analysis
Caroline A. Schneider et al.
NATURE METHODS (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Usp7 and Uhrf1 Control Ubiquitination and Stability of the Maintenance DNA Methyltransferase Dnmt1
Weihua Qin et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2011)
An Atlas of Altered Expression of Deubiquitinating Enzymes in Human Cancer
Chiara Luise et al.
PLOS ONE (2011)
Regulation of MITF stability by the USP13 deubiquitinase
Xiansi Zhao et al.
NATURE COMMUNICATIONS (2011)
Lys11-linked ubiquitin chains adopt compact conformations and are preferentially hydrolyzed by the deubiquitinase Cezanne
Anja Bremm et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2010)
Differential expression analysis for sequence count data
Simon Anders et al.
GENOME BIOLOGY (2010)
MDM2-Dependent Downregulation of p21 and hnRNP K Provides a Switch between Apoptosis and Growth Arrest Induced by Pharmacologically Activated p53
Martin Enge et al.
CANCER CELL (2009)
Defining the Human Deubiquitinating Enzyme Interaction Landscape
Mathew E. Sowa et al.
CELL (2009)
Proteins involved in pRb and p53 pathways are differentially expressed in thin and thick superficial spreading melanomas
Bianca Costa Soares de Sa et al.
MELANOMA RESEARCH (2009)
Dynamic assembly of chromatin complexes during cellular senescence: implications for the growth arrest of human melanocytic nevi
Debdutta Bandyopadhyay et al.
AGING CELL (2007)
The DAVID Gene Functional Classification Tool: a novel biological module-centric algorithm to functionally analyze large gene lists
Da Wei Huang et al.
GENOME BIOLOGY (2007)
Protocol for micro-purification, enrichment, pre-fractionation and storage of peptides for proteomics using StageTips
Juri Rappsilber et al.
NATURE PROTOCOLS (2007)
Ubiquitin ligases: cell-cycle control and cancer
KI Nakayama et al.
NATURE REVIEWS CANCER (2006)
In-gel digestion for mass spectrometric characterization of proteins and proteomes
Andrej Shevchenko et al.
NATURE PROTOCOLS (2006)
A genomic and functional inventory of deubiquitinating enzymes
SMB Nijman et al.
CELL (2005)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
S phase-specific transcription of the mouse ribonucleotide reductase R2 gene requires both a proximal repressive E2F-binding site and an upstream promoter activating region
AL Chabes et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Mouse ribonucleotide reductase R2 protein: A new target for anaphase-promoting complex-Cdh1-mediated proteolysis
AL Chabes et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Share Paper
